Paul J Fielder - Vice President, PTPK & ITGR/OMNI Biomarker Development

Paul J Fielder

Vice President, PTPK & ITGR/OMNI Biomarker Development

"Many Scientists aspire to help discover and develop a life changing therapeutic for a significant unmet medical need. At Genentech, we have had the privilege of helping to make this a reality for thousands of patients. To be a part of this mission is both humbling and inspiring."
24
Years at Genentech
55
Publications
3
Awards & Honors

After completing my Ph.D. at UCSC and Postdoctoral fellowship at Stanford, I joined Genentech in 1993 as a Scientist to help develop a new field studying the Pharmacokinetics and Pharmacodynamics of protein therapeutics. I was drawn to Genentech because of its great scientific reputation and it offered me the best opportunity to pursue great science in the mission of helping patients.

Over my career at Genentech, I have had the privilege of contributing to the discovery and development of multiple therapeutics, as well as, the training and development of our next generation of scientists and drug developers.

Featured Publication

Evidence for an asialoglycoprotein receptor on nonparenchymal cells for O-linked glycoproteins.

Journal of Pharmacology and Experimental Therapeutics. 2008 Nov;327(2):308-15.

Stefanich EG, Ren R, Danilenko DM, Lim A, Song A, Iyer S, Fielder PJ.

The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults.

Journal of Clinical Endocrinology & Metabolism. 87(10):4508-14, 2002 Oct.

Cook DM. Biller BM. Vance ML. Hoffman AR. Phillips LS. Ford KM. Benziger DP. Illeperuma A. Blethen SL. Attie KM. Dao LN. Reimann JD. Fielder PJ.